Results 291 to 300 of about 718,142 (310)
Some of the next articles are maybe not open access.
Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates
Ca-A Cancer Journal for Clinicians, 2006David M Goldenberg
exaly
1-Hour plasma glucose in referred populations: functional marker or overstated risk?
Diabetes Research and Clinical PracticeHong Li, Yuxuan Zhang, Jie Zhang
openaire +1 more source
Pharmacogenetics and pharmacogenomics of anticancer agents
Ca-A Cancer Journal for Clinicians, 2009R Stephanie Huang
exaly
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Nature Reviews Clinical Oncology, 2020Nora Pashayan +2 more
exaly
Identifying genetic markers of adaptation for surveillance of viral host jumps
Nature Reviews Microbiology, 2010Kim M Pepin +2 more
exaly
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC
Nature Reviews Clinical Oncology, 2019Ross Camidge, Robert C Doebele
exaly
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Nature Reviews Clinical Oncology, 2017Tsukasa Shibue, Robert A Weinberg
exaly
NTRK fusion-positive cancers and TRK inhibitor therapy
Nature Reviews Clinical Oncology, 2018Emiliano Cocco +2 more
exaly

